Equities

Tibet Rhodiola Pharmaceutical Holding Co

600211:SHH

Tibet Rhodiola Pharmaceutical Holding Co

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)35.97
  • Today's Change-0.41 / -1.13%
  • Shares traded3.16m
  • 1 Year change-13.79%
  • Beta2.8083
Data delayed at least 15 minutes, as of Jun 07 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.

  • Revenue in CNY (TTM)2.93bn
  • Net income in CNY810.63m
  • Incorporated1999
  • Employees601.00
  • Location
    Tibet Rhodiola Pharmaceutical Holding CoNo. 19, Beijing Middle RoadLASA 850000ChinaCHN
  • Phone+86 2 886653915
  • Fax+86 2 886660740
  • Websitehttp://www.xzyy.cn
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NanJing Pharmaceutical Co Ltd53.46bn587.75m6.09bn4.90k10.300.9142--0.1140.45130.451341.075.091.638.333.3310,903,610.002.222.327.448.946.046.411.361.301.132.910.635929.826.7111.35-3.0016.93-12.679.86
Guangxi LiuYao Group Co Ltd21.25bn888.87m8.66bn5.58k8.821.13--0.40752.462.4658.8219.121.076.991.973,807,204.004.805.0611.7312.2111.5611.854.474.401.305.260.543429.909.2312.1821.119.97-8.636.26
GuangYuYuan Chinese Herbal Medicn Co Ltd1.26bn121.59m10.99bn1.81k90.427.15--8.740.24840.24842.573.140.47010.76611.99694,836.904.96-2.107.42-3.1671.4369.7410.56-6.001.1612.910.1569--13.56-4.53136.03-24.78-58.35--
Tibet Rhodiola Pharmaceutical Holding Co2.93bn810.63m11.98bn601.0013.252.52--4.092.812.819.6514.760.60161.816.684,877,892.0016.8312.4423.1815.7193.6890.5127.9720.432.797.960.171650.4122.6924.98116.5630.01-1.4848.97
China Meheco Group Co Ltd35.07bn924.87m16.38bn8.39k17.711.40--0.46710.61830.618323.447.830.92244.582.284,180,309.002.963.406.727.7611.2214.153.212.931.228.890.33528.223.284.6042.45-7.466.72-1.02
Data as of Jun 07 2024. Currency figures normalised to Tibet Rhodiola Pharmaceutical Holding Co's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

4.20%Per cent of shares held by top holders
HolderShares% Held
China Southern Asset Management Co., Ltd.as of 31 Dec 20233.49m1.08%
HuaAn Fund Management Co., Ltd.as of 31 Dec 20231.93m0.60%
China Asset Management Co., Ltd.as of 31 Dec 20231.64m0.51%
Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 20231.58m0.49%
The Vanguard Group, Inc.as of 09 May 2024945.63k0.29%
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023910.10k0.28%
Rongtong Fund Management Co., Ltd.as of 31 Dec 2023892.88k0.28%
Baoying Fund Management Co., Ltd.as of 31 Dec 2023793.13k0.25%
Penghua Fund Management Co., Ltd.as of 31 Dec 2023735.41k0.23%
China Universal Asset Management Co., Ltd.as of 31 Dec 2023608.79k0.19%
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.